Company intelligence / Profile preview

Ironridge Global IV

San Francisco

Ownership: Private
Development stage: Other

Overview

Ironridge Global IV, Ltd. was a subsidiary of Ironridge Global Partners, LLC that engaged in equity financing of micro-cap public companies. The firm operated through a "Liabilities for Equity" (LIFE) financing program that arranged purchases of outstanding claims from creditors and settled them through Section 3(a)(10) exchanges[5]. The firm received and sold approximately 5.5 billion shares through this mechanism, generating net profits of about $22 million[5]. However, the firm settled SEC violations in 2024 for $4.4 million in disgorgement related to operating as an unregistered broker-dealer[5].

Industry: Investors

Partnerships

PositiveID Corporation ($5 million)Genetic Technologies Limited ($5 million)Pressure BioSciences ($500,000)Advaxis, Inc.Amarantus Biosciences ($511,310 settlement claim)

Beyond the preview

Go deeper on Ironridge Global IV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ironridge Global IV.

Explore the full profile